CIFU', Adriana
 Distribuzione geografica
Continente #
NA - Nord America 1.493
EU - Europa 400
AS - Asia 166
AF - Africa 5
OC - Oceania 2
SA - Sud America 1
Totale 2.067
Nazione #
US - Stati Uniti d'America 1.489
IT - Italia 148
DE - Germania 48
UA - Ucraina 45
CN - Cina 43
TR - Turchia 38
VN - Vietnam 38
BE - Belgio 36
IN - India 32
IE - Irlanda 31
SE - Svezia 27
GB - Regno Unito 24
FR - Francia 23
IR - Iran 9
RO - Romania 6
EG - Egitto 5
CA - Canada 4
AU - Australia 2
ES - Italia 2
HK - Hong Kong 2
RS - Serbia 2
AM - Armenia 1
AT - Austria 1
CL - Cile 1
CZ - Repubblica Ceca 1
FI - Finlandia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
LV - Lettonia 1
NL - Olanda 1
PL - Polonia 1
SG - Singapore 1
Totale 2.067
Città #
Chandler 262
Fairfield 153
Woodbridge 109
Ann Arbor 91
Ashburn 81
Seattle 79
Dearborn 75
Wilmington 71
Houston 55
Cambridge 53
Dong Ket 38
Izmir 38
Udine 38
Brussels 36
Princeton 32
Dublin 30
Jacksonville 30
Beijing 24
Redmond 24
Venezia 21
Trieste 15
San Diego 12
Boardman 7
Leawood 7
Norwalk 7
Ansbach 6
Augusta 6
Nanjing 5
Ogden 5
Redwood City 5
San Mateo 5
Cagliari 4
Cairo 4
Cinisello Balsamo 4
Des Moines 4
Milan 4
Pune 4
Tavagnacco 4
Brentino Belluno 3
Calvenzano 3
Falls Church 3
Grafing 3
Halle 3
Kashan 3
Monmouth Junction 3
Mumbai 3
New Delhi 3
Phoenix 3
Postioma 3
Verona 3
Belgrade 2
Chions 2
Fuzhou 2
Hefei 2
Hong Kong 2
Kunming 2
Monferrato 2
New York 2
Ottawa 2
Torre Del Greco 2
Wuhan 2
Amsterdam 1
Ardabil 1
Azor 1
Boydton 1
Brisbane 1
Brno 1
Budapest 1
Chongqing 1
Como 1
Dallas 1
Denver 1
Düsseldorf 1
Eugene 1
Frankfurt am Main 1
Hebei 1
Henderson 1
Kish 1
London 1
Madrid 1
Mesagne 1
Miami 1
Montreal 1
Nanchang 1
Orlando 1
Paris 1
Pesaro 1
Phnom Penh 1
Riga 1
Rome 1
Ronchis 1
Sacramento 1
Santiago 1
Scafati 1
Sligo 1
Sydney 1
Taizhou 1
Tappahannock 1
Toronto 1
Vienna 1
Totale 1.545
Nome #
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies 200
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis 184
Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes 163
Potential Role of Exosomes in Countering Vedolizumab-Based Therapy in IBD Patients 134
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 130
Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells 118
Pharmacogenetic Determinants of Response to Infliximab in Pediatric Inflammatory Bowel Disease. 74
Clinical applications of microenvironment-controlled immunosuppressive properties of mesenchymal stem cells-derived exosomes: a review 69
Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes 67
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Gonarthrosis. 66
The role of tumor-derived exosomes in cancer immune evasion mediated by toll-like receptor 4 activation 63
Comparison between Anti-β2Glycoprotein I Antibody and Anti-Phosphatidylserine/Prothrombin Antibody Biological Effects on Peripheral Blood Monocytes 63
Asymmetrical Dimethylarginine (ADMA) In Asympomatic Cerebral Small Vessel Disease. 62
Do circulating exosomes interfere with vedolizumab efficacy in IBD patients? 58
To investigate in vitro the pathogenic mechanism of anti-PS/PT antibodies to better define their role in the diagnosis of APS syndrome 57
Characterization of Parotid Gland Epithelial Cell Primary Cultures from Patients Affected by Sjogren’s Syndrome 52
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 50
The Effect of Serum of Cerebral Small Vessel Disease Patients on Brain Endothelial Cells 49
Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity is Significantly Associated with High Risk Anti-Phospholipid Antibody Antigenic Specificities . 47
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 46
The Effect of Osteoarthritic Synovial Fluid on Immunomodulatory Properties of Adipose Mesenchymal Stem Cells. 46
The immunomodulatory properties of adipose mesenchymal stem cell-derived exosomes are induced by inflammatory cytokines . 45
Anti-phosphatidylserine/prothrombin Autoantibodies Significantly Improve The Laboratory Diagnostic Process Of Anti-phospholipids Antibody Syndrome. 45
Toll-like Receptor-4 Activation Improves the Immunosuppressive Properties of Cancer Cells-Derived Exosomes. 40
Circulating exosomes express α4β7 integrin and compete with CD4+ T cells for the binding to Vedolizumab 39
Preliminary Evaluation of a new immunofluorescence mosaic assay for inflammatory bowel disease diagnosis: a pilot study in Udine 37
The Exposure to Osteoarthritic Synovial Fluid Enhances the Immunomodulatory Profile of Adipose Mesenchymal Stem Cell Secretome 36
A large biomarker investigation in young asymptomatic patients with cerebral vessel disease identified ADMA as a possible key molecule driving endothelial damage. 33
Comparison between anti-β2 Glycoprotein I antibody and anti-phosphatidyserine/prothrombin antibody pro-thrombotic effects on peripheral blood monocytes and endothelial cells . 31
Tumor Exosomes Mediate the Horizontal Transfer of DNA Gene Mutation 30
The influence of a stressful microenvironment on tumor exosomes: a focus on the DNA cargo 28
Validation of a One-Step Reverse Transcription-Droplet Digital PCR (RT-ddPCR) Approach to Detect and Quantify SARS-CoV-2 RNA in Nasopharyngeal Swabs 26
Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma 4
Totale 2.192
Categoria #
all - tutte 7.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.059


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019205 0 0 0 0 0 0 0 0 21 88 69 27
2019/2020474 23 17 15 57 47 91 49 42 41 58 16 18
2020/2021485 11 114 9 45 24 26 20 43 66 24 50 53
2021/2022310 12 25 13 21 3 11 15 19 8 41 104 38
2022/2023514 40 51 2 92 38 104 6 62 71 5 23 20
2023/2024112 18 17 6 7 21 17 2 11 13 0 0 0
Totale 2.192